Investors just getting started shouldn’t look any further than the FTSE 100, I feel. It offers the highest-quality stocks to consider buying.
Of its 100 constituents, many are household names. They sell products that people use and consume every day.
For investors starting out, here are two I reckon they should consider buying today.
British American Tobacco
First in line is British American Tobacco (LSE: BATS). Now, I know what people may think. Why buy shares in this company? It operates in a dying industry, right?
Well, maybe. And I’m not disregarding the challenges it may face in the years ahead. However, I feel British American Tobacco is a strong enough business to overcome them.
Firstly, it’s aware of this trend, so it’s diversifying. Its New Categories division sells non-combustible goods such as tobacco-free nicotine pouches and vapour products. It’s home to many brands quickly growing in popularity, such as Velo. Last year, organic revenue for the division grew an impressive 21%.
To go alongside its growth in new areas, I also like the fact that the stock has a high dividend yield. It currently sits at 10.2%, the third-highest on the Footsie.
Dividend payments are never guaranteed. Events, such as the pandemic, which seriously hurt a company’s profits, can see them reduce or cut dividends in an attempt to save money.
However, with British American Tobacco, I’m confident that it will keep paying its shareholders. That’s because it has done so for the last 24 years, meaning it has earned its label as a Dividend Aristocrat.
Its share price has suffered in the last 12 months. During that time, it has fallen 18.2%. However, that means that its shares now look ridiculously cheap. As I write, they trade on a price-to-earnings (P/E) ratio of just 6.5. I think that’s too good to pass on.
GSK
For my second pick, let’s turn the attention to pharmaceutical giant GSK (LSE: GSK).
There are many reasons why I like the look of GSK stock today. Firstly, it has strong brand recognition and a dominant market position.
On top of that, it’s also a defensive stock. By this, I mean it will have demand for its products regardless of the macroeconomic environment. With the UK in a ‘technical recession’, owning stocks of this nature seems like a smart idea.
GSK yields 3.5%. Going forward, that’s predicted to rise to over 4%, which is above the 3.9% FTSE 100 average.
Of course, there are potential risks to consider. Pharma companies are always prone to R&D complications. Researching and creating drugs or treatments can cost millions to bring to market, so there’s that to consider.
Nevertheless, as management’s heavy investment in improving its future pipeline seems to be working, I’m bullish on GSK’s future prospects.
It isn’t just me who has this view though. Citigroup recently raised GSK stock to a ‘buy’ recommendation. That’s the first time in seven years. It’s also predicted that the business will grow earnings at 9.4% a year to the end of 2026.
Like British American Tobacco, I believe its shares look cheap. Their P/E ratio of 10.5 is slightly lower than the Footsie average of 11. On top of that, the stock is considerably cheaper than many of its competitors.
The post 2 of the best FTSE 100 beginner stocks to consider buying appeared first on The Motley Fool UK.
5 stocks for trying to build wealth after 50
Inflation recently hit 40-year highs… the ‘cost of living crisis’ rumbles on… the prospect of a new Cold War with Russia and China looms large, while the global economy could be teetering on the brink of recession.
Whether you’re a newbie investor or a seasoned pro, deciding which stocks to add to your shopping list can be a daunting prospect during such unprecedented times. Yet despite the stock market’s recent gains, we think many shares still trade at a discount to their true value.
Fortunately, The Motley Fool UK analyst team have short-listed five companies that they believe STILL boast significant long-term growth prospects despite the global upheaval…
We’re sharing the names in a special FREE investing report that you can download today. We believe these stocks could be a great fit for any well-diversified portfolio with the goal of building wealth in your 50’s.
Claim your free copy now
More reading
I’d build an extra income with a spare £3 a day like this
Is GSK’s share price the best bargain in the FTSE 100?
“The last FTSE 100 stock I’d sell in a recession is…”
2 FTSE stocks I’d be willing to put 100% of my money into for passive income!
858 shares in this FTSE 100 dividend giant can make me £3,013 in passive income each month
Citigroup is an advertising partner of The Ascent, a Motley Fool company. Charlie Keough has positions in British American Tobacco P.l.c. The Motley Fool UK has recommended British American Tobacco P.l.c. and GSK. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.
